GE Healthcare Subsidiary to Build KUBio Factory in China and 2 Other Dow Movers to Watch

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

General Electric Co. (NYSE:GE): Current price $24.41

GE Healthcare’s GE Healthcare Life Sciences and JHL Biotech, which provides biopharmaceutical process development and manufacturing services, announced that a KUBio modular biopharmaceutical factory will be constructed in China for JHL Biotech. The location for the new facility, which is expected to be fully operational by early 2015, is the Biolake Science Park in Wuhan. GE Healthcare’s innovative turnkey approach will entail the assembly at the JHL Biotech site of pre-made modules equipped with GE Healthcare’s technologies for the start-to-finish manufacture of biopharmaceuticals.

ge-20130925

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business